Cargando…

Comparative Evaluation of Chiglitazar and Sitagliptin on the Levels of Retinol-Binding Protein 4 and Its Correlation With Insulin Resistance in Patients With Type 2 Diabetes

AIMS: We evaluated the efficacy and significant changes in the levels of retinol-binding protein 4 (RBP-4) and insulin resistance in patients with type 2 diabetes mellitus (T2DM) treated with chiglitazar versus sitagliptin. METHODS: Eighty-one T2DM patients with haemoglobin A1c (HbA1c) level of 7.5%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yunting, Wang, Huiying, Wang, Yuming, Xu, Xiaohua, Li, Fengfei, Zhou, Junming, Shan, Ting, Huang, Rong, Cai, Tingting, Liu, Xiaomei, Su, Xiaofei, Li, Huiqin, Ma, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081976/ https://www.ncbi.nlm.nih.gov/pubmed/35547000 http://dx.doi.org/10.3389/fendo.2022.801271

Ejemplares similares

Basal Insulin Reduces Glucose Variability and Hypoglycaemia Compared to Premixed Insulin in Type 2 Diabetes Patients: A Study Based on Continuous Glucose Monitoring Systems
por: Wang, Huiying, et al.
Publicado: (2022)

Vitamin A and Its Multi-Effects on Pancreas: Recent Advances and Prospects
por: Zhou, Yunting, et al.
Publicado: (2021)

Increased Glycemic Variability Evaluated by Continuous Glucose Monitoring is Associated with Osteoporosis in Type 2 Diabetic Patients
por: Huang, Rong, et al.
Publicado: (2022)

Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring
por: Wang, Huiying, et al.
Publicado: (2021)

Perilipin 2 Protects against Lipotoxicity-Induced Islet Fibrosis by Inducing Islet Stellate Cell Activation Phenotype Changes
por: Zhou, Yunting, et al.
Publicado: (2022)

Effect of Metformin on Testosterone Levels in Male Patients With Type 2 Diabetes Mellitus Treated With Insulin
por: Cai, Tingting, et al.
Publicado: (2021)

Personalized glucose-lowering effect of chiglitazar in type 2 diabetes
por: Huang, Qi, et al.
Publicado: (2023)

In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist
por: He, B. K., et al.
Publicado: (2012)

Ethnicity Differences in the Association of UCP1-3826A/G, UCP2-866G/A and Ala55Val, and UCP3-55C/T Polymorphisms with Type 2 Diabetes Mellitus Susceptibility: An Updated Meta-Analysis
por: Huang, Rong, et al.
Publicado: (2021)

Chiglitazar Preferentially Regulates Gene Expression via Configuration-Restricted Binding and Phosphorylation Inhibition of PPARγ
por: Pan, De-Si, et al.
Publicado: (2017)

Associaton of Retinol Binding Protein 4 (RBP4) Levels With Hyperuricemia: A Cross-Sectional Study in a Chinese Population
por: Hong, Guo-bao, et al.
Publicado: (2022)

Anticipated correlation between lean body mass to visceral fat mass ratio and insulin resistance: NHANES 2011-2018
por: Shao, Ya, et al.
Publicado: (2023)

Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis
por: Lin, Chu, et al.
Publicado: (2023)

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
por: Wang, Xingchun, et al.
Publicado: (2022)

Sexual Dimorphism in the Association of Serum Retinol-Binding Protein-4 With Long-Term Dynamic Metabolic Profiles in Non-Diabetes
por: Xiang, Jiali, et al.
Publicado: (2022)

Vitamin A deficiency causes islet dysfunction by inducing islet stellate cell activation via cellular retinol binding protein 1
por: Zhou, Yunting, et al.
Publicado: (2020)

The Retinol Circulating Complex Releases Hormonal Ligands During Acute Stress Disorders
por: Ingenbleek, Yves
Publicado: (2018)

Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches
por: Qi, Jian-hong, et al.
Publicado: (2023)

Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial
por: Yang, Lin, et al.
Publicado: (2021)

Unresponsive Intractable Chronic Headache With Sitagliptin
por: Zaghloul, Ahmed, et al.
Publicado: (2018)

To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated Receptors by Pan-Agonist Chiglitazar Using Molecular Dynamics Simulations
por: Sullivan, Holli-Joi, et al.
Publicado: (2020)

Preconception Prebiotic and Sitagliptin Treatment in Obese Rats Affects Pregnancy Outcomes and Offspring Microbiota, Adiposity, and Glycemia
por: Dennison, Carol A., et al.
Publicado: (2017)

Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs
por: Luo, Menghui, et al.
Publicado: (2020)

The Optimized Calculation Method for Insulin Dosage in an Insulin Tolerance Test (ITT): A Randomized Parallel Control Study
por: Zhang, Yuwen, et al.
Publicado: (2020)

Response to the Letter to the Editor from Valdemar Grill et al: “Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial”
por: Liang, Huiying, et al.
Publicado: (2021)

LRP6 Knockdown Ameliorates Insulin Resistance via Modulation of Autophagy by Regulating GSK3β Signaling in Human LO2 Hepatocytes
por: Li, Lei, et al.
Publicado: (2019)

Sitagliptin Stimulates Endothelial Progenitor Cells to Induce Endothelialization in Aneurysm Necks Through the SDF-1/CXCR4/NRF2 Signaling Pathway
por: Yu, Guo, et al.
Publicado: (2019)

A Rare Case Report of Sitagliptin-Induced Angioedema
por: Sharma, Nava R, et al.
Publicado: (2022)

A clinical observation study on the effect of needle-free insulin syringe on blood glucose control and well-being index in patients with early-onset type 2 diabetes mellitus
por: Jin, Xiaolong, et al.
Publicado: (2023)

The role of peripheral β-amyloid in insulin resistance, insulin secretion, and prediabetes: in vitro and population-based studies
por: Xu, Zihui, et al.
Publicado: (2023)

The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial
por: Al Sifri, S, et al.
Publicado: (2011)

Maternal sitagliptin treatment attenuates offspring glucose metabolism and intestinal proinflammatory cytokines IL-6 and TNF-α expression in male rats
por: Zhang, Qian, et al.
Publicado: (2020)

Fatty Acid Profiles and Their Association With Autoimmunity, Insulin Sensitivity and β Cell Function in Latent Autoimmune Diabetes in Adults
por: Tian, Huiqin, et al.
Publicado: (2022)

Subclinical hypothyroidism increases insulin resistance in normoglycemic people
por: Yang, Wanyu, et al.
Publicado: (2023)

Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2022)

Pharmacokinetics, pharmacodynamics, and safety of prandial oral insulin (N11005) in healthy subjects
por: Pan, Qi, et al.
Publicado: (2023)

Sitagliptin-induced Pancreatitis: Chronic Use Would Not Spare You the Complication
por: Alkayali, Talal, et al.
Publicado: (2020)

OR17-07 Retinol Binding Protein 4 Predicts Functional Vascular Disease in Early Postmenopausal Women
por: Armeni, Eleni, et al.
Publicado: (2020)

Twenty Minute Moderate-Intensity Post-Dinner Exercise Reduces the Postprandial Glucose Response in Chinese Patients with Type 2 Diabetes
por: Li, Zheng, et al.
Publicado: (2018)

Sirtuins and Insulin Resistance
por: Zhou, Shuang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_okii4rb43huo9fgsq722mbbbpu